Clinical research on Zimmer® M/L Taper Hip Prosthesis with Kinectiv™ Technology

Not Applicable

• Conditions: Patients who have been diagnosed secondary hip osteoarthritis with acetabular dysplasia (Crowe classification; type I to IV)

• Registration Number: JPRN-UMIN000004220
• Lead Sponsor: Shonan Kamakura Joint Reconstruction Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-16
• Study Completion: 2013-07-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1)A patient who underwent artificial joint replacement or osteotomy of the affected lower limb 2)A patient with infection-like symptoms such as osteomyelitis of the proximal femur and suppurative infection of the hip joint. 3)A patient with neuromuscular disorder (Charcot's joint, etc.) in the affected limb 4)A patient who are skeletally immature 5)A patient with loss or atrophy of the abductor muscle in the affected limb 6)A patient with insufficient bone mass (due to steroid-induced metabolic bone disorder, etc.) 7)A patient with insufficient skin coverage around the hip joint 8)A patient with local or systemic infection 9)A patient with the stove-pipe femur 10)A patients with suspected metal allergies 11)Other patients who are determined to be ineligible for total hip arthroplasty and this study by the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To investigate the consistency of stem component/neck component of the M/L Taper Kinectiv Stem selected through preoperative 3D-templating and the device actually implanted

Secondary Outcome Measures

Name	Time	Method
To investigate clinical outcomes(JOA score, Harris Hip Score, SF-12 and X-ray) for 24-month postoperatively